Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Gross Margin for 6 consecutive years, with 70.55% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 684.0% to 70.55% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 64.03% through Dec 2025, up 1132.0% year-over-year, with the annual reading at 64.03% for FY2025, 1132.0% up from the prior year.
  • Gross Margin hit 70.55% in Q4 2025 for Rapid Micro Biosystems, up from 63.06% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 70.55% in Q4 2025 to a low of 5.72% in Q4 2022.
  • Historically, Gross Margin has averaged 43.16% across 5 years, with a median of 47.13% in 2021.
  • Biggest five-year swings in Gross Margin: crashed -3933bps in 2022 and later skyrocketed 4440bps in 2023.
  • Year by year, Gross Margin stood at 35.58% in 2021, then crashed by -84bps to 5.72% in 2022, then skyrocketed by 777bps to 50.12% in 2023, then increased by 27bps to 63.71% in 2024, then grew by 11bps to 70.55% in 2025.
  • Business Quant data shows Gross Margin for RPID at 70.55% in Q4 2025, 63.06% in Q3 2025, and 57.12% in Q2 2025.